Artivion, Inc., formerly known as Aortech International, is a leading medical technology company headquartered in the United States. Founded in 2000, Artivion has established itself in the cardiovascular industry, focusing on innovative solutions for cardiac and vascular surgery. The company is renowned for its advanced bioengineered products, including the Aorfix™ stent graft, which offers unique features for treating aortic aneurysms. With a strong presence in North America and expanding operations in Europe and Asia, Artivion is committed to enhancing patient outcomes through its cutting-edge technologies. The company has achieved significant milestones, including regulatory approvals and partnerships that bolster its market position. Artivion continues to be recognised for its dedication to innovation and quality in the medical device sector, making it a trusted name among healthcare professionals worldwide.
How does Artivion, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Artivion, Inc.'s score of 25 is lower than 54% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2021, Artivion, Inc. reported total carbon emissions of approximately 6,116,000 kg CO2e, comprising 5,051,000 kg CO2e from Scope 1, 558,000 kg CO2e from Scope 2, and 1,051,000 kg CO2e from Scope 3 emissions. The company has not disclosed any specific reduction targets or initiatives as part of its climate commitments. Artivion's emissions data is not cascaded from any parent organisation, indicating that these figures are solely representative of its own operations. As a company headquartered in the US, Artivion is positioned within an industry increasingly focused on sustainability and carbon footprint reduction, yet it currently lacks formal commitments to specific climate initiatives or targets.
Access structured emissions data, company-specific emission factors, and source documents
| 2021 | |
|---|---|
| Scope 1 | 5,051,000 | 
| Scope 2 | 558,000 | 
| Scope 3 | 1,051,000 | 
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Artivion, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
